Evidence map›Paper›PMID 36500928›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Synthesis of CuO/GO-DE Catalyst and Its Catalytic Properties and Mechanism on Ciprofloxacin Degradation.

Ting Zhang, Jingjing Zhang, Yinghao Yu, Jinxu Li, Zhifang Zhou, Chunlei Li

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Synthesis and characterization of a copper oxide/bismuth molybdate heterostructure for ciprofloxacin degradation via photoelectrocatalysis.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ting ZhangSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.ORCID 0000-0001-6500-2937
Jingjing ZhangSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
Yinghao YuSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
Jinxu LiSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
Zhifang ZhouSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
Chunlei LiSchool of Petrochemical Engineering, Lanzhou University of Technology, Lanzhou 730050, China.
Lanzhou University of Technology · CN

Funding

Major Science and Technology Projects in Gansu Province of China 21ZD2JA001
6 · The paper itself

Abstract

A new catalyst, copper oxide/graphene oxide-diatomaceous earth (CuO/GO-DE), was prepared by the ultrasonic impregnation method. The optimal conditions for catalyst preparation were explored, and its structure and morphology were characterized by BET, XRD, SEM, TEM, FTIR, Raman and XPS. By taking ciprofloxacin as the target pollutant, the performance and reusability of CuO/GO-DE to degrade antibiotic wastewater was evaluated, and the optimal operating conditions were obtained. The main oxidizing substances in the catalytic system under different pH conditions were analyzed, as well as the synergistic catalytic oxidation mechanism. The intermediate products of ciprofloxacin degradation were identified by LC-MS, and the possible degradation process of ciprofloxacin was proposed.

Indexed as

catalytic mechanismciprofloxacincopper oxidediatomaceous earthgraphene oxide

Identifiers

PMID36500928
PMCPMC9740731
OpenAlexW4311282688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.